Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00089310 · ClinicalTrials.gov registry record · NA
Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer
A NA study of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 12
- Study locations
NCT00089310: Completed NA study of Lung Cancer, sponsored by Alliance for Clinical Trials in Oncology.
NCT00089310 is a NA study of Lung Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 46 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 12 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00089310, a NA study of Lung Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 12
- Study locations
Study Summary
RATIONALE: Diagnostic procedures such as sentinel lymph node mapping may improve the ability to detect cancer that has spread to the lymph nodes. PURPOSE: This clinical trial is studying how well sentinel lymph node mapping works in detecting cancer that has spread to the lymph nodes in patients who are undergoing surgery for stage I non-small cell lung cancer.
Conditions Studied
Interventions
- RADIATION technetium-99
Study Locations (12)
New York
- Roswell Park Cancer Institute - Buffalo
- Elmhurst Hospital Center - Elmhurst
- Queens Cancer Center of Queens Hospital - Jamaica
- Mount Sinai Medical Center - New York
- SUNY Upstate Medical University Hospital - Syracuse
Delaware
- Beebe Medical Center - Lewes
- CCOP - Christiana Care Health Services - Newark
Illinois
- Evanston Northwestern Healthcare - Evanston Hospital - Evanston
Missouri
- Veterans Affairs Medical Center - Columbia (Truman Memorial) - Columbia
New Jersey
- Cancer Institute of New Jersey at Cooper - Voorhees - Voorhees Township
North Carolina
- Veterans Affairs Medical Center - Asheville - Asheville
Ohio
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-04 |
| Phase | NA |
What the finished NCT00089310 record still lists
NCT00089310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which technetium-99 is the first listed.
NCT00089310 lists 12 locations in 7 states (New York, Delaware, Illinois).
Frequently Asked Questions
What is clinical trial NCT00089310 about?
NCT00089310 is a clinical study titled "Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer". RATIONALE: Diagnostic procedures such as sentinel lymph node mapping may improve the ability to detect cancer that has spread to the lymph nodes. PURPOSE: This clinical trial is studying how well sentinel lymph node mapping works in detecting cancer that has spread to the lymph nodes in patients wh...
What is the current status of trial NCT00089310?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2004-09. Estimated completion is 2009-04.
What conditions does trial NCT00089310 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00089310?
The interventions under investigation include: technetium-99 (RADIATION).
Who is sponsoring clinical trial NCT00089310?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00089310 being conducted?
This trial has 12 study locations across Delaware, Illinois, Missouri, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00089310's enrollment target sits among peer trials
46 275th of 409 higher than 131 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia